in Archives - Page 20 of 51 - Family Medicine News

Prophylaxis for gonococcal eye infections in newborns advised

30.01.2019 Health Problems

(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) has reaffirmed the recommendation for use of ocular prophylaxis for gonococcal ophthalmia neonatorum. This recommendation forms the basis of a final recommendation statement published online Jan. 29 in the Journal of the American Medical Association. Susan J. Curry, Ph.D., from the University of Iowa in Iowa City, and colleagues used a reaffirmation deliberation […]

Important signaling pathway in breast cancer revealed

25.01.2019 Health Problems

Researchers at Kanazawa University report in Proceedings of the National Academy of Sciences (PNAS) that a particular signaling pathway in breast cancer tumors causes cancer cells to divide symmetrically, expanding the tumor. Inhibiting the pathway with drugs could become a strategy for eliminating the cancer cells. In breast cancer, one of the most common cancers in women, tumors contain a […]

Genetic risk for ADHD manifests in brain structure in childhood

25.01.2019 Health Problems

There is only scant scientific evidence available on whether the genetic risk for developing specific psychiatric disorders or cognitive traits is manifest in brain structure from childhood, and to date, studies have focused primarily on adult populations. The question remains unanswered. New evidence has now been provided by a study led by a researcher from the Barcelona Institute for Global […]

Insulin price more than doubled in the US

24.01.2019 Health Problems

(HealthDay)—Some Americans with type 1 diabetes have cut back on their insulin usage as the cost of the drug nearly doubled over a five-year period. The annual amount that patients with type 1 diabetes spent on the drug rose from about $2,900 in 2012 to about $5,700 in 2016, according to a new analysis from the nonprofit Health Care Cost […]

Gene-edited disease monkeys cloned in China

23.01.2019 Health Problems

The first cohort of five gene-edited monkey clones made from fibroblasts of a monkey with disease phenotypes were born recently at the Institute of Neuroscience (ION) of the Chinese Academy of Sciences (CAS) in Shanghai. The expression of BMAL1, a core circadian regulatory transcription factor, was knocked out in the donor monkey using CRISPR/Cas9-mediated gene editing at the embryo stage, […]

Researchers discover new type of blood vessel in the bones of mice

23.01.2019 Health Problems

A team of researchers affiliated with multiple institutions across Germany has discovered a new type of blood vessel in mouse bones. In their paper published in the journal Nature Metabolism, the group describes making sample mouse bones transparent, as well as their microscopic properties. Christopher Ritchlin and Iannis Adamopoulos with the University of Rochester and the University of California, respectively, […]

Injuries from burns in Kenya affect mostly children and happen in homes

23.01.2019 Kids Health

An estimated 180,000 people die every year worldwide as a result of burns and survivors often suffer terribly. Burn injuries are particularly common in low- and middle-income countries. It’s estimated that burns are the cause of 20% of all trauma seen at Kenyatta National Hospital, one of two national referral hospitals in Kenya. We did a study on patients admitted […]

The metabolism of the intestinal microbiota in the first year of life

22.01.2019 Health Problems

A research team with the participation of the Institute for Integrative Systems Biology (I2SysBio) of the University of Valencia, together with FISABIO and CIBERESP, has carried out the first metatranscriptomic study of the gut microbiota of babies, which extends knowledge of the metabolism of intestinal bacterial communities during the first year of life with an unprecedented level of detail. This […]

Fighting deadly drug resistant bacteria in intestines with new antibiotic

19.01.2019 Health Problems

A new antibiotic developed by a Flinders University researcher is being heralded as a breakthrough in the war against a drug resistant superbug. Bacteria are winning the fight against antibiotics as they evolve to fight off traditional treatments, threatening decades of advancements in modern medicine, with predictions they will kill over 10 million people by 2050. The scientific development of […]

Engineered immune cells target broad range of pediatric solid tumors in mice

17.01.2019 Health Problems

Immune cells engineered to attack childhood cancers were able to eradicate different types of pediatric tumors in mice, according to a new study from the Stanford University School of Medicine. The study, which will be published online Jan. 17 in Clinical Cancer Research, provides evidence that these engineered cells can target many types of pediatric solid tumors, including brain tumors. […]

« 1 … 18 19 20 21 22 … 51 »